Navigation Links
Alimera Sciences To Release Second Quarter 2014 Results
Date:7/24/2014

ATLANTA, July 24, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter of fiscal year 2014 financial results after the market close on Thursday, August 7, 2014. An investor conference call will follow on the same day at 4:30 p.m. ET.

The conference call will be hosted by Dan Myers, President and Chief Executive Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial Officer.

To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at http://www.alimerasciences.com.

A replay of the conference call will be available beginning August 7, 2014 at 7:30 p.m. ET and ending on August 14, 2014 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 77034836. A replay of the webcast will also be available on the corporate website.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its wholly-owned subsidiary, Alimera Sciences Limited.

Investor Contact:
ICR, LLC
John M
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
2. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
3. Alimera Sciences Names European Management Team
4. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
5. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
6. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
7. Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results
8. Alimera Sciences Secures $20 Million Debt Facility
9. Alimera Sciences Reports First Quarter 2013 Financial Results
10. Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results
11. Alimera Sciences Reports Second Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... FREMONT, Calif. , July 7, 2015  The ... and Velos, Inc. have entered into a seven year ... research nationally throughout South Korea and ... signing was accompanied by a two day joint workshop between ... Korea.  National Cancer Center President Dr. Lee ...
(Date:7/7/2015)... , Kalifornien, 7. Juli 2015 /PRNewswire/ ... Medizintechnikunternehmen, das sich der Entwicklung innovativer Geräte ... heute den Zugang von R. Michael ... Herr Kleine verfügt über eine ... Medizintechnik und Gesundheitsfürsorge. Er hat verschiedene globale ...
(Date:7/7/2015)... Md. , July 7, 2015 ... (CRO) focusing in Oncology, Vaccines, and General Medicine ... the final locked database to Heron Therapeutics, Inc. ... 3 receptor antagonist product candidate SUSTOL® (granisetron ... regimen with the IV NK 1 receptor ...
Breaking Medicine Technology:National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... ALTO, Calif., Jan. 10, 2012 Varian Medical Systems (NYSE: ... a new radiotherapy treatment planning tool designed to work with ... the amount of time needed for planning advanced treatments. ... clinician must take the patient,s anatomical images and identify and ...
... Agreement allows development for potential treatment of chronic constipation ... SHPGY ), the global specialty biopharmaceutical company, announced today ... market Resolor ® (prucalopride) in the United States ... of the agreement have not been disclosed. ...
Cached Medicine Technology:Varian Medical Systems Receives FDA 510(k) Clearance for Software that Speeds Up Radiotherapy Treatment Planning 2Shire Acquires US Rights to Resolor(R) (prucalopride) 2Shire Acquires US Rights to Resolor(R) (prucalopride) 3Shire Acquires US Rights to Resolor(R) (prucalopride) 4
(Date:7/8/2015)... ... July 08, 2015 , ... Health & Disability ... on July 29th in Bettendorf, IA. This workshop will be presented to community-based ... members, veterans, and their families. Professionals from both civilian and military organizations are ...
(Date:7/8/2015)... (PRWEB) , ... July 08, 2015 , ... Garden ... offering the finest full body massage in NYC. The attractive masseuses that staff Garden ... atmosphere for customers to relax and unwind. With plenty of parking, and a location ...
(Date:7/7/2015)... ... July 08, 2015 , ... The National Association of ... its VIP Woman of the Year Circle. She is recognized with this prestigious distinction ... women, boasting more than 700,000 members and over 200 operating Local Chapters. , “I’m ...
(Date:7/7/2015)... ... July 07, 2015 , ... World Patent ... Tube Holder, a medical invention that prevents IV lines from getting entangled. ... which will be worth $133 billion by 2016," says Scott Cooper, CEO and ...
(Date:7/7/2015)... ... 07, 2015 , ... Researchers at UC Davis have reviewed ... didn’t) and how similar programs can be improved. , Interviewing staff, clinicians and ... of Practice (HEALTH COP) program, the team identified four factors that helped clinicians ...
Breaking Medicine News(10 mins):Health News:Health & Disability Advocates to Host Military Sexual Trauma Workshop for Behavioral Health Practitioners and Victim Advocates 2Health News:Garden Retreat Spa Celebrates 8 Years Serving NYC 2Health News:National Association of Professional Women Inducts Dr. Alyssa Greedy, Pharm. D., Pharmacy Manager at Walgreens, Into its VIP Woman of the Year Circle 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3
... to improve the quality and safety of health ... Patient Safety Organizations,(PSOs) was announced today by the ... PSOs are private entities recognized by the Secretary ... health care providers. They are,new and separate from ...
... Medicine, by Maria Siemionow, ... M.D., ... for a moment, being unable to touch the face of someone you,love. "Now ... Maria Siemionow, section head of plastic,surgery research at Cleveland Clinic ( http://www.clevelandclinic.org/ ), ...
... the University of North Carolina at Chapel Hill shows for ... to function at the cell surface also functions at a ... for drug development as they involve G protein-coupled receptors (GPCRs). ... of modern medicinal drugs, such as antihistamines and drugs for ...
... The Chicago Tribune has published a,feature story on ... the,problem, implications for loving dog owners, and treatments and ... link at end of release.,Morris Animal Foundation (MAF) is ... in the next 10 to 20 years. MAF can ...
... of Sheffield and STFC Rutherford-Appleton Laboratories have developed one ... heart of future medical scanners. The new technology will ... of the human body at a lower-cost to the ... developed as part of the 4.5m Basic Technology MI-3 ...
... new services to energy workers, WASHINGTON, Feb. ... enhanced services to assist nuclear weapons industry,workers with ... department,s resource centers will now work one-on-one,with claimants ... under the Energy Employees Occupational Illness Compensation,Program Act ...
Cached Medicine News:Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 2Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 3Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 4Health News:Cleveland Clinic Press Releases Book About a Surgeon's Mission to Perform the World's First Full Face Transplant 2Health News:Discovery of 'overdrive' protein could broaden drug design options 2Health News:U.S. Labor Department Increases Claim Assistance for Energy Workers 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
Medicine Products: